Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aaronson, 1991, The EORTC core quality of life questionnaire: interim results of an international field study, 185
Aaronson, 1993, The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, J. Natl. Cancer Inst., 85, 365, 10.1093/jnci/85.5.365
Andersen, 1994, A biobehavioral model of cancer stress and disease course, Am. Psychol., 49, 389, 10.1037/0003-066X.49.5.389
Aragona, 1996, Lymphocyte number and stress parameter modifications in untreated breast cancer patients with depressive mood and previous life stress, J. Exp. Ther. Oncol., 1, 354
Bartsch, 1985, Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: relationship with the pituitary hormones, J. Pineal Res., 2, 121, 10.1111/j.1600-079X.1985.tb00633.x
Blauer, 1991, Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation, Endocrinology, 129, 3174, 10.1210/endo-129-6-3174
Carlson, 1999, Relationships among cortisol (CRT), dehydroepiandrosterone-sulfate (DHEAS), and memory in a longitudinal study of healthy elderly men and women, Neurobiol. Aging, 20, 315, 10.1016/S0197-4580(99)00052-4
Carlson, 2001, The effects of a mindfulness meditation based stress reduction program on mood and symptoms of stress in cancer outpatients: six month follow-up, Support. Care Cancer, 9, 112, 10.1007/s005200000206
Carlson, L.E., Speca, M., Patel, K.D., Goodey, E., in press. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and immune parameters in breast and prostate cancer outpatients. Psychosom. Med.
Cassileth, 1998, Alternative and complementary cancer therapies, Cancer, 77, 1026, 10.1002/(SICI)1097-0142(19960315)77:6<1026::AID-CNCR4>3.0.CO;2-F
Cassileth, 1985, Psychosocial status of cancer patients and next of kin: normative data from the profile of mood states, J. Psychosoc. Oncol., 3, 99, 10.1300/J077v03n03_08
Cohen, 1991, Stress and infectious diseases in humans, Psychol. Bull., 109, 5, 10.1037/0033-2909.109.1.5
Cos, 1998, Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells, Cancer Res., 58, 4383
Courneya, 2001, Exercise interventions during cancer treatment: biopsychosocial outcomes, Exerc. Sport Sci. Rev., 29, 60, 10.1097/00003677-200104000-00004
Courneya, 1999, Physical exercise and quality of life following cancer diagnosis: a literature review, Ann. Behav. Med., 21, 171, 10.1007/BF02908298
Cruess, 1999, Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEAS) and increases in the cortisol/DHEAS ratio and reduces mood disturbance and perceived stress among HIV-seropostive men, Psychoneuroendocrinology, 24, 537, 10.1016/S0306-4530(99)00010-4
Cruess, 2000, Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer, Psychosom. Med., 62, 304, 10.1097/00006842-200005000-00002
Deepak, 1994, Meditation improves clinicoelectroencephalographic measures in drug-resistant epileptics, Biofeedback Self Regul., 19, 25, 10.1007/BF01720668
DeFlorio, 1995, Review of depression in cancer: gender differences, Depression, 3, 66, 10.1002/depr.3050030112
Derogatis, 1983, The prevalence of psychiatric disorders among cancer patients, J. Am. Med. Assoc., 249, 751, 10.1001/jama.1983.03330300035030
Dorgan, 1997, Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women, Cancer Epidemiol. Biomarkers Prev., 6, 177
Ernst, 1998, The prevalence of complementary/alternative medicine in cancer: a systematic review, Cancer, 83, 777, 10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O
Esterling, 1996, Psychosocial modulation of cytokine-induced natural killer cell activity in older adults, Psychosom. Med., 58, 264, 10.1097/00006842-199605000-00010
Feldman, 2001, Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study, Am. J. Epidemiol., 153, 79, 10.1093/aje/153.1.79
Friedenreich, 2001, Relation between intensity of physical activity and breast cancer risk reduction, Med. Sci. Sports Exerc., 33, 1538, 10.1097/00005768-200109000-00018
Glaser, 1992, Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs, J. Behav. Med., 15, 327, 10.1007/BF00844726
Gordon, 1990, Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone-sulfate to the risk of developing postmenopausal breast cancer, Cancer Res., 50, 3859
Guazzo, 1996, Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age, J. Clin. Endocrinol. Metab., 81, 3951
Henderson, 1989
Heuser, 1998, Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients, J. Clin. Endocrinol. Metab., 83, 3130, 10.1210/jcem.83.9.5081
Hornsby, 1995, Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline, Ann. N. Y. Acad. Sci., 774, 29, 10.1111/j.1749-6632.1995.tb17370.x
Johannes, 1999, Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women’s Health Study, J. Clin. Epidemiol., 52, 95, 10.1016/S0895-4356(98)00144-9
Kabat-Zinn, 1982, An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results, Gen. Hosp. Psychiatry, 4, 33, 10.1016/0163-8343(82)90026-3
Kabat-Zinn, 1990
Kabat-Zinn, 1987, Four-year follow-up of a meditation based program for the self-regulation of chronic pain: treatment outcomes and compliance, Clin. J. Pain, 2, 159, 10.1097/00002508-198602030-00004
Kabat-Zinn, 1992, Effectivenes of a meditation-based stress reduction program in the treatment of anxiety disorders, Am. J. Psychiatry, 149, 943
Kabat-Zinn, 1998, Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to sever psoriasis undergoing phototherpay (UVB) and photochemotherapy (PUVA), Psychosom. Med., 60, 625, 10.1097/00006842-199809000-00020
Kailajarvi, 2000, Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids, Anticancer Res., 20, 1323
Kanno, 1997, Effect of restraint stress on immune system and experimental B melanoma metastasis in aged mice, Mech. Ageing Dev., 93, 107, 10.1016/S0047-6374(96)01827-1
Kaplan, 1993, The impact of a meditation-based stress reduction program on fibromyalgia, Gen. Hosp. Psychiatry, 15, 284, 10.1016/0163-8343(93)90020-O
Keller, 1999, Ilness-related distress: does it mean the same for men and women?, Acta Oncol., 38, 747, 10.1080/028418699432905
Kirschbaum, 1994, Salivary cortisol in psychoneuroendocrine research: recent developments and applications, Psychoneuroendocrinology, 19, 313, 10.1016/0306-4530(94)90013-2
Laakso, 1990, Correlation between salivary and serum melatonin: dependence on serum melatonin levels, J. Pineal Res., 9, 39, 10.1111/j.1600-079X.1990.tb00692.x
Leckie, 1979
Lissoni, 1997, Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone, Eur. Urol., 31, 178, 10.1159/000474446
Lissoni, 1999, Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status, Eur. J. Cancer, 35, 1688, 10.1016/S0959-8049(99)00159-8
Lissoni, 1999, Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study, J. Pineal Res., 26, 169, 10.1111/j.1600-079X.1999.tb00579.x
Lonning, 1995, Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients, J. Steroid Biochem. Mol. Biol., 52, 491, 10.1016/0960-0760(94)00189-S
MacLean, 1994, Altered responses of cortisol, GH, TSH and testosterone to acute stress after four months’ practice of transcendental meditation (TM), Ann. N. Y. Acad. Sci., 746, 381, 10.1111/j.1749-6632.1994.tb39261.x
Majewska, 1995, Neuronal action of dehydroepiandrosterone: possible roles in brain development, aging, memory and affect, Ann. N. Y. Acad. Sci., 774, 111, 10.1111/j.1749-6632.1995.tb17375.x
Massion, 1995, Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data, Med. Hypotheses, 44, 39, 10.1016/0306-9877(95)90299-6
Mazat, 2001, Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality, Proc. Natl. Acad. Sci. U.S.A., 98, 8145, 10.1073/pnas.121177998
McEwen, 1995, Stress and cognitive function, Curr. Opin. Neurobiol., 5, 205, 10.1016/0959-4388(95)80028-X
McIntyre, 1987, Melatonin rhythm in human plasma and saliva, J. Pineal Res., 4, 177, 10.1111/j.1600-079X.1987.tb00854.x
McNair, 1971
Michelson, 2000, Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population, Acta Oncol., 39, 477, 10.1080/028418600750013384
Miller, 1995, Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders, Gen. Hosp. Psychiatry, 17, 192, 10.1016/0163-8343(95)00025-M
Morales, 1994, Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age, J. Clin. Endocrinol. Metab., 78, 1360
Mormont, 1997, Circadian-system alterations during cancer processes: a review, Int. J. Cancer, 70, 241, 10.1002/(SICI)1097-0215(19970117)70:2<241::AID-IJC16>3.0.CO;2-L
National Cancer Institute of Canada, 2001. Canadian Cancer Statistics 2001. Toronto, Ontario: National Cancer Institute of Canada.
Reibel, 2001, Mindfulness-based stress reduction and health-related quality of life in a heterogeneous patient population, Gen. Hosp. Psychiatry, 23, 183, 10.1016/S0163-8343(01)00149-9
Riska, 1999, Mental distress: gender aspects of symptoms and coping, Acta Oncol., 38, 757, 10.1080/028418699432914
Schedlowski, 1994, Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: an exploratory study, Psycho-Oncology, 3, 181, 10.1002/pon.2960030304
Schneider, 1995, A randomised controlled trial of stress reduction for hypertension in older African Americans, Hypertension, 26, 820, 10.1161/01.HYP.26.5.820
Sephton, 2000, Diurnal cortisol rhythm as a predictor of breast cancer survival, J. Natl. Cancer Inst., 92, 944, 10.1093/jnci/92.12.994
Shirtcliff, 2001, Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results, Psychoneuroendocrinology, 26, 165, 10.1016/S0306-4530(00)00042-1
Sikes, 1989, Cognitive sequelae of hypothalamic-pituitary-adrenal (HPA) dysregulation in depression, Biol. Psychiatry, 25, 148A, 10.1016/0006-3223(89)91784-8
Singh, 1998, A pilot study of cognitive behavioral therapy in fibromyalgia, Altern. Ther. Health Med., 4, 67
Speca, 2000, A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients, Psychosom. Med., 62, 613, 10.1097/00006842-200009000-00004
Spiegel, 1998, Effects of psychosocial treatment in prolonging cancer survival may be mediated by neuroimmune pathways, Ann. N. Y. Acad. Sci., 840, 674, 10.1111/j.1749-6632.1998.tb09606.x
Strain, 1998, Adjustment disorders, 509
Sudsuang, 1991, Effect of Buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time, Physiol. Behav., 50, 543, 10.1016/0031-9384(91)90543-W
Tamarkin, 1982, Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer, Science, 216, 1003, 10.1126/science.7079745
Ticher, 1996, The pattern of hormonal circadian time structure (acrophase) as an assessor of breast-cancer risk, Int. J. Cancer, 65, 591, 10.1002/(SICI)1097-0215(19960301)65:5<591::AID-IJC6>3.0.CO;2-Y
Tooley, 2000, Acute increases in night-time plasma melatonin levels following a period of meditation, Biol. Psychol., 53, 69, 10.1016/S0301-0511(00)00035-1
Touitou, 1996, Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens, Br. J. Cancer, 74, 1248, 10.1038/bjc.1996.524
Turner-Cobb, 2000, Social support and salivary cortisol in women with metastatic breast cancer, Psychosom. Med., 62, 337, 10.1097/00006842-200005000-00007
van der Pompe, 1997, Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study, J. Psychosom. Res., 42, 453, 10.1016/S0022-3999(96)00393-5
van der Pompe, 1996, Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer, Psychoneuroendocrinology, 21, 361, 10.1016/0306-4530(96)00009-1
Vermeulen, 1995, Dehydroepiandrosterone sulfate and aging, Ann. N. Y. Acad. Sci., 774, 121, 10.1111/j.1749-6632.1995.tb17376.x
Vijayalaxmi, 2002, Melatonin: from basic research to cancer treatment clinics, J. Clin. Oncol., 20, 2575, 10.1200/JCO.2002.11.004
Voultsios, 1997, Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin, J. Biol. Rhythms, 12, 457, 10.1177/074873049701200507
Walton, 1995, Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism, J. Altern. Complement. Med., 1, 263, 10.1089/acm.1995.1.263
Wolkowitz, 1994, Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids, Psychoneuroendocrinology, 3, 233, 10.1016/0306-4530(94)90064-7
Wolkowitz, 1997, DHEA treatment of depression, Biol. Psychiatry, 41, 311, 10.1016/S0006-3223(96)00043-1